FSSAI issues notices to Dr Reddy's, Nestle Health Science, Amazon, Flipkart over misleading health claims
Synopsis
FSSAI has put India's biggest pharma, nutrition, and e-commerce names on notice — Dr Reddy's, Nestle Health Science, Amazon, Flipkart, and Netmeds among them — over allegedly misleading protein and muscle-health claims. The move marks a significant expansion of the regulator's labelling crackdown to online marketplaces, not just manufacturers.
Key Takeaways
FSSAI issued notices to Dr Reddy's , Nestle Health Science , Tirupati Wellness , Amazon , Flipkart , and Netmeds on 8 October 2026 .
Products allegedly carried misleading claims on high protein content , lean muscle mass , muscle strength , immunity support , and energy metabolism .
Companies have been asked to explain why regulatory action should not be initiated against them.
FSSAI also cited non-compliant advertising , sale of unsafe food , and sale of expired/rotten food products in its statement.
The action extends FSSAI's scrutiny to online marketplaces for the first time alongside product manufacturers.
The Food Safety and Standards Authority of India (FSSAI) on Thursday, 8 October 2026, issued notices to Dr Reddy's, Nestle Health Science, Tirupati Wellness, Amazon, Flipkart, and Netmeds over allegedly misleading health claims on products marketed for protein support and lean muscle mass maintenance. The food safety regulator has asked each company to explain why regulatory action should not be initiated against them.
What the Notices Allege
According to FSSAI, the flagged products carried claims related to high protein content, maintenance of lean muscle mass, muscle strength, immunity support, and energy metabolism. The regulator contends that these claims were presented on product packaging in a manner that could potentially mislead consumers about the actual health benefits associated with the products.
The notices seek detailed explanations from the companies regarding both the nature of the claims and the manner in which they were communicated to consumers. The companies will be required to respond to the regulator's concerns before any further regulatory action is considered.
What FSSAI Said
In a post on Instagram, FSSAI stated: 'FSSAI takes action against Dr. Reddy's and Nestle Health Science Limited, Nex International and Shreyash Retail Pvt. Ltd. for non-compliant advertising and misleading claims, sale of unsafe food, and sale of expired/rotten food products, respectively.'
The regulator added: 'FSSAI remains committed to ensuring safe and wholesome food, protecting consumer interests and taking stringent action against violations of food safety requirements.'
Broader Crackdown on Health Labelling
This action comes amid intensified scrutiny by FSSAI of the marketing and labelling of food and nutrition products carrying health and nutritional benefit claims. The regulator has been consistently emphasising that such claims must be presented accurately and must not create misleading impressions about the benefits consumers can expect. Notably, the inclusion of major e-commerce platforms — Amazon, Flipkart, and Netmeds — signals that the regulator is extending oversight beyond manufacturers to online marketplaces that host and sell such products.
What Happens Next
The named companies are expected to file formal responses to FSSAI's notices. Depending on the explanations provided, the regulator may choose to initiate formal enforcement proceedings, impose penalties, or direct product relabelling or withdrawal. The outcome will have broader implications for the fast-growing health supplement and functional food segment in India, where label claims frequently outpace regulatory compliance.
Point of View
Flipkart, and Netmeds in FSSAI's notice round is the real story here — it signals that the regulator is ready to hold digital shelves to the same standard as physical ones. India's health supplement market has long operated in a grey zone where label claims outpace clinical backing and regulatory enforcement has been sporadic. What FSSAI has not yet clarified is whether e-commerce platforms are being treated as passive conduits or active publishers of the misleading claims — a distinction that will determine the legal and commercial weight of any eventual penalty. Without a clear compliance framework for online health product listings, a show-cause notice risks being no more than a speed bump for a sector growing at double digits.
NationPress
8 Oct 2026
Frequently Asked Questions
Why has FSSAI issued notices to Dr Reddy's and Nestle Health Science?
FSSAI issued notices to Dr Reddy's and Nestle Health Science on 8 October 2026 over allegedly misleading health claims on products marketed for protein support and lean muscle mass maintenance. The regulator said these claims, related to high protein content, muscle strength, immunity support, and energy metabolism, were presented in a way that could potentially mislead consumers.
Why are Amazon, Flipkart, and Netmeds included in the FSSAI notices?
Amazon, Flipkart, and Netmeds received notices because they are among the platforms through which the flagged products were sold to consumers. The inclusion of online marketplaces indicates FSSAI is expanding its oversight beyond manufacturers to digital retailers hosting products with non-compliant health claims.
What happens after the FSSAI notices are issued?
The companies named in the notices are required to respond to FSSAI's concerns with explanations about the nature of the claims and how they were presented. Depending on the responses, FSSAI may initiate formal enforcement proceedings, impose penalties, or direct product relabelling or withdrawal.
What types of claims did FSSAI flag as potentially misleading?
FSSAI flagged claims related to high protein content, maintenance of lean muscle mass, muscle strength, immunity support, and energy metabolism. The regulator said these were presented on product packaging in a manner that could create misleading impressions about the health benefits of the products.
What is FSSAI's broader position on health and nutrition labelling?
FSSAI has been increasing scrutiny of health and nutritional benefit claims on food products, emphasising that such claims must be accurate and must not mislead consumers. The 8 October 2026 action is part of an ongoing regulatory push to bring food marketing and labelling into compliance with food safety standards.
